新发风湿性多肌痛中的亚临床巨细胞动脉炎:个体患者数据的系统评价与荟萃分析
该系统评价与个体患者数据荟萃分析纳入13个队列共566例新发风湿性多肌痛(PMR)患者,亚临床巨细胞动脉炎(GCA)总体汇总患病率为23%(95%CI 14%-36%,I²=84%),PET/(CT)筛查研究为29%(95%CI 13%-53%,I²=85%)。基于243例PET/(CT)筛查患者个体数据的预测模型曲线下面积为0.66(95%CI 0.55-0.75),诊断准确性仅为中等。
要点
- 新发PMR患者中亚临床GCA的汇总患病率为23%,PET/(CT)筛查研究中为29%。
- 炎性背痛、无下肢疼痛、女性、体温>37°、体重下降、血小板计数和血红蛋白水平与亚临床GCA相关。
- 基于上述变量的预测模型曲线下面积为0.66(95%CI 0.55-0.75),诊断准确性仅为中等。
核心结论
- 超过四分之一的PMR患者可能患有亚临床GCA。
- 基于最广泛个体患者数据集的预测模型诊断准确性仅为中等。
- 因此,应讨论PMR患者评估模式的转变,以倾向于实施影像学研究。
研究设计与样本
- 系统检索PubMed、Embase和Web of Science Core Collection(最后检索日期2021年7月14日),纳入报告无颅神经或缺血症状的未使用激素的PMR患者中亚临床GCA患病率的连续招募队列。
- 采用随机效应荟萃分析合并各人群患病率,并利用PET/(CT)筛查队列的个体患者数据进行混合效应逻辑回归识别亚临床GCA的潜在预测因素。
- 共纳入1965年至2020年发表的13个队列、566例患者;亚临床GCA分别由颞动脉活检(3项研究)、超声(3项研究)和PET/(CT)(7项研究)诊断。
主要发现
- 所有研究中亚临床GCA的汇总患病率为23%(95%CI 14%-36%,I²=84%)。
- 使用PET/(CT)的研究中亚临床GCA的汇总患病率为29%(95%CI 13%-53%,I²=85%,n=266例患者)。
- 单变量分析中与亚临床GCA相关性最强的因素包括:炎性背痛(OR 2.73,1.32-5.64)、无下肢疼痛(OR 2.35,1.05-5.26)、女性(OR 2.31,1.17-4.58)、体温>37°(OR 1.83,0.90-3.71)、体重下降(OR 1.83,0.96-3.51)、血小板计数(OR 1.51,1.05-2.18)和血红蛋白水平(OR 0.80,0.64-1.00)。
- C反应蛋白(OR 1.00,1.00-1.01)和红细胞沉降率(OR 1.01,1.00-1.02)与亚临床GCA无显著关联。
- 基于上述变量计算的预测模型曲线下面积为0.66(95%CI 0.55-0.75)。
关键数值与推荐
- 亚临床GCA的汇总患病率(所有筛查方法)为23%(95%CI 14%-36%,I²=84%)。
- PET/(CT)筛查研究中亚临床GCA的汇总患病率为29%(95%CI 13%-53%,I²=85%,n=266例患者)。
- 预测模型曲线下面积为0.66(95%CI 0.55-0.75)。
- 炎性背痛OR 2.73(1.32-5.64),无下肢疼痛OR 2.35(1.05-5.26),女性OR 2.31(1.17-4.58),体温>37°OR 1.83(0.90-3.71),体重下降OR 1.83(0.96-3.51),血小板计数OR 1.51(1.05-2.18),血红蛋白水平OR 0.80(0.64-1.00)。
临床怎么用
- 作者认为,应讨论PMR患者评估模式的转变,以倾向于实施影像学研究。
局限性
- 所有研究中亚临床GCA汇总患病率的异质性I²=84%。
- PET/(CT)研究中亚临床GCA汇总患病率的异质性I²=85%。
- 预测模型曲线下面积为0.66(95%CI 0.55-0.75),诊断准确性仅为中等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the prevalence and predictors of subclinical giant cell arteritis (GCA) in patients with newly diagnosed polymyalgia rheumatica (PMR). METHODS: PubMed, Embase, and Web of Science Core Collection were systematically searched (date of last search July 14, 2021) for any published information on any consecutively recruited cohort reporting the prevalence of GCA in steroid-naïve patients with PMR without cranial or ischemic symptoms. We combined prevalences across populations in a random-effect meta-analysis. Potential predictors of subclinical GCA were identified by mixed-effect logistic regression using individual patient data (IPD) from cohorts screened with PET/(CT). RESULTS: We included 13 cohorts with 566 patients from studies published between 1965 to 2020. Subclinical GCA was diagnosed by temporal artery biopsy in three studies, ultrasound in three studies, and PET/(CT) in seven studies. The pooled prevalence of subclinical GCA across all studies was 23% (95% CI 14%-36%, I2=84%) for any screening method and 29% in the studies using PET/(CT) (95% CI 13%-53%, I2=85%) (n=266 patients). For seven cohorts we obtained IPD for 243 patients screened with PET/(CT). Inflammatory back pain (OR 2.73, 1.32-5.64), absence of lower limb pain (OR 2.35, 1.05-5.26), female sex (OR 2.31, 1.17-4.58), temperature >37° (OR 1.83, 0.90-3.71), weight loss (OR 1.83, 0.96-3.51), thrombocyte count (OR 1.51, 1.05-2.18), and haemoglobin level (OR 0.80, 0.64-1.00) were most strongly associated with subclinical GCA in the univariable analysis but not C-reactive protein (OR 1.00, 1.00-1.01) or erythrocyte sedimentation rate (OR 1.01, 1.00-1.02). A prediction model calculated from these variables had an area under the curve of 0.66 (95% CI 0.55-0.75). CONCLUSION: More than a quarter of patients with PMR may have subclinical GCA. The prediction model from the most extensive IPD set has only modest diagnostic accuracy. Hence, a paradigm shift in the assessment of PMR patients in favour of implementing imaging studies should be discussed.
引用
- Hemmig AK, Gozzoli D, Werlen L, et al. Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data. Semin Arthritis Rheum. 2022. PMID: 35537222. doi:10.1016/j.semarthrit.2022.152017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。